All of the current treatment and advances in the management of heart disease that prolong and improve the lives of patients with heart disease have been achieved through carefully regulated research. Academic Cardiology participates in several clinical medication trials approved by the FDA according in accordance with Good Clinical Practices.

RELY Study

Compares new anti blood clotting drug to warfarin for prevention of stroke in atrial fibrillation. Enrollment is completed for this study.

dal-OUTCOMES Study

Determines if adding a medication to raise HDL levels (“good” cholesterol) will reduce the risk of heart attacks and death in patients who have had a recent heart attack.
This study is currently enrolling new patients

AVERROES Study

Compared the effectiveness of a new anti blood clotting medication to aspirin in patient with atrial fibrillation. This study is currently enrolling new patients.

ENGAGE-AF

Evaluate the effectiveness of a new anti blood clotting drug to replace warfarin for prevention of stroke in atrial fibrillation.

Enrollment will begin in November 2008.

If you are interested in participating or learning more about these research studies, contact our office and ask for the research nurse.